Active	Status	Sponsor type	Region	Phase	Filter
3 Active 4 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kaski, Juan Carlos
CEDAR-HCM, NCT06412666: A Study to Evaluate the Effect of Aficamten in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).	Recruiting	2/3	40	Europe, Canada, US	Aficamten, Placebo	Cytokinetics	Pediatric, Symptomatic Obstructive Hypertrophic Cardiomyopathy	12/28	12/28
NCT06092034: A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease	Active, not recruiting	2	12	Europe, US	RP-A501	Rocket Pharmaceuticals Inc.	Danon Disease	09/25	09/29
NCT06214507: Danon Disease Natural History Study	Recruiting	N/A	46	Europe, US, RoW	No intervention	Rocket Pharmaceuticals Inc.	Danon Disease	08/26	08/26
Reiter, Russel J
No trials found